BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 37453831)

  • 1. Oestrogen-based therapies for menopausal symptoms.
    Laing A; Hillard T
    Best Pract Res Clin Endocrinol Metab; 2024 Jan; 38(1):101789. PubMed ID: 37453831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oestrogen and progestogen hormone replacement therapy for peri-menopausal and post-menopausal women: weight and body fat distribution.
    Norman RJ; Flight IH; Rees MC
    Cochrane Database Syst Rev; 2000; (2):CD001018. PubMed ID: 10796730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oestrogen therapy for urinary incontinence in post-menopausal women.
    Cody JD; Jacobs ML; Richardson K; Moehrer B; Hextall A
    Cochrane Database Syst Rev; 2012 Oct; 10(10):CD001405. PubMed ID: 23076892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oestrogen therapy for urinary incontinence in post-menopausal women.
    Cody JD; Richardson K; Moehrer B; Hextall A; Glazener CM
    Cochrane Database Syst Rev; 2009 Oct; (4):CD001405. PubMed ID: 19821277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-contraceptive oestrogen-containing preparations for controlling symptoms of premenstrual syndrome.
    Naheed B; Kuiper JH; Uthman OA; O'Mahony F; O'Brien PM
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD010503. PubMed ID: 28257559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local oestrogen for vaginal atrophy in postmenopausal women.
    Lethaby A; Ayeleke RO; Roberts H
    Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD001500. PubMed ID: 27577677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The management of menopause in women with a history of endometriosis: a systematic review.
    Gemmell LC; Webster KE; Kirtley S; Vincent K; Zondervan KT; Becker CM
    Hum Reprod Update; 2017 Jul; 23(4):481-500. PubMed ID: 28498913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sex hormones and the cardiovascular system: effects on arterial function in women.
    Teede HJ
    Clin Exp Pharmacol Physiol; 2007 Jul; 34(7):672-6. PubMed ID: 17581228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. European Menopause and Andropause Society (EMAS) and International Gynecologic Cancer Society (IGCS) position statement on managing the menopause after gynecological cancer: focus on menopausal symptoms and osteoporosis.
    Rees M; Angioli R; Coleman RL; Glasspool R; Plotti F; Simoncini T; Terranova C
    Maturitas; 2020 Apr; 134():56-61. PubMed ID: 32059825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of hormone replacement therapy and route of administration on selected cardiovascular risk factors in post-menopausal women.
    Seed M; Sands RH; McLaren M; Kirk G; Darko D
    Fam Pract; 2000 Dec; 17(6):497-507. PubMed ID: 11120722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of menopausal symptoms: what shall we do now?
    Hickey M; Davis SR; Sturdee DW
    Lancet; 2005 Jul 30-Aug 5; 366(9483):409-21. PubMed ID: 16054942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Local oestrogen for vaginal atrophy in postmenopausal women.
    Suckling J; Lethaby A; Kennedy R
    Cochrane Database Syst Rev; 2006 Oct; (4):CD001500. PubMed ID: 17054136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Local oestrogen for vaginal atrophy in postmenopausal women.
    Suckling J; Lethaby A; Kennedy R
    Cochrane Database Syst Rev; 2003; (4):CD001500. PubMed ID: 14583935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The route of administration, timing, duration and dose of postmenopausal hormone therapy and cardiovascular outcomes in women: a systematic review.
    Oliver-Williams C; Glisic M; Shahzad S; Brown E; Pellegrino Baena C; Chadni M; Chowdhury R; Franco OH; Muka T
    Hum Reprod Update; 2019 Mar; 25(2):257-271. PubMed ID: 30508190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hormone replacement therapy in postmenopausal women: endometrial hyperplasia and irregular bleeding.
    Lethaby A; Suckling J; Barlow D; Farquhar CM; Jepson RG; Roberts H
    Cochrane Database Syst Rev; 2004; (3):CD000402. PubMed ID: 15266429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oestrogen replacement in postmenopausal women.
    Sassarini J; Lumsden MA
    Age Ageing; 2015 Jul; 44(4):551-8. PubMed ID: 26070875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Managing menopausal symptoms after cancer: an evidence-based approach for primary care.
    Marino JL; McNamara HC; Hickey M
    Med J Aust; 2018 Feb; 208(3):127-132. PubMed ID: 29438648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification of the adverse effect of ethinylestradiol containing oral contraceptive pills when used in conjunction with growth hormone replacement in routine practice.
    Phelan N; Conway SH; Llahana S; Conway GS
    Clin Endocrinol (Oxf); 2012 May; 76(5):729-33. PubMed ID: 22098528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormone replacement therapy in postmenopausal women: endometrial hyperplasia and irregular bleeding.
    Lethaby A; Farquhar C; Sarkis A; Roberts H; Jepson R; Barlow D
    Cochrane Database Syst Rev; 2000; (2):CD000402. PubMed ID: 10796715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term hormone therapy for perimenopausal and postmenopausal women.
    Marjoribanks J; Farquhar C; Roberts H; Lethaby A; Lee J
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD004143. PubMed ID: 28093732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.